Abstract
In addition to their classical hormonal role, the neurohypophyseal peptides vasopressin (AVP) and oxytocin (OT) are also implicated as regulators of growth and development. Mitogenic actions of AVP are particularly well characterized and may underly the potential role of AVP as an autocrine regulator of tumor growth. Effects of AVP and OT on neural development are suggested by numerous studies, but definitive physiological evidence is lacking. Current studies on the molecular characterization of AVP and OT receptors, and on transgenic animals will provide insights into the developmental actions of neurohypophyseal peptides.
Similar content being viewed by others
References
Almazan G., Lefebvre D. L., and Zingg H. H. (1989) Ontogeny of hypothalamic vasopressin, oxytocin and somataostatin gene expression.Dev. Brain Res. 45, 69–75.
Alstein M. and Gainer H. (1988) Differential biosynthesis and post-translational processing of vasopressin and oxytocin in rat brain during embryonic and postnatal development.J. Neurosci. 8, 3967–3977.
Altman J. and Bayer S. A. (1978) Development of the diencephalon in the rat. I. Autoradiographic study of the time of origin and settling patterns of neurons in the hypothalamus.J. Comp. Neurol. 182, 945–972.
Ang H-L., Funkhouser J., Carter D. A., Ho M-Y., and Murphy D. (1991) Expression of bovine vasopressin in the hypothalamus of the transgenic mouse and its regulation during osmotic challenge.Soc. Neurosci. Abstr. 21, 513.12.
Antoni F. A. (1984) Novel ligand specificity of pituitary vasopressin receptors in the rat.Neuroendocrinology 39, 186–188.
Arimura A., Sawano S., Redding T. W., and Schally A. V. (1968) Studies on retarded growth of rats with hereditary hypothalamic diabetes insipidus.Neuroendocrinology 3, 187–192.
Bartter F. C. and Schwartz W. B. (1967) The syndrome of inappropriate secretion of antidiuretic hormone.Am. J. Med. 42, 790–806.
Boer G. J. (1985) Vasopressin and brain development: Studies using the Brattleboro rat.Peptides 6(Suppl. 1), 49–62.
Brinton R. E. and Gruener R. (1987) Vasopressin promotes neurite growth in cultured embryonic neurons.Synapse 1, 329–334.
Bunn P. A., Dienhart D. G., Chan D., Puck T. T., Tagawa M., Jewett P. B., and Braunschweiger E. (1990) Neuropeptide stimulation of calcium flux in human lung cancer cells: Delineation of alternative pathways.Proc. Natl. Acad. Sci. USA 87, 2162–2166.
Chooi K-F., Carter D. A., Biswas S., Lightman S. L., and Murphy D. (1991) Vasopressin gene expression and carcinogenesis in the mammary gland of transgenic mice.Abstracts of the 4th International Congress on Hormones and Cancer, Amsterdam, p. 436.
Clements J. A. and Funder J. W. (1988) Arginine vasopressin and oxytocin in organs outside the nervous system, inFrontiers in Neuroendocrinology, vol. 10, Martini L. and Ganong W. F., eds., Raven, New York, pp. 117–152.
Collins M. K. L. and Rozengurt E. (1983) Vasopresin induces selective desensitization of its mitogenic response in Swiss 3T3 cells.Proc. Natl. Acad. Sci. USA 80, 1924–1928.
Corps A. N., Rees L. H., and Brown K. D. (1985) A peptide that inhibits the mitogenic stimulation of Swiss 3T3 cells by bombesin or vasopressin.Biochem. J. 231, 781–784.
Cuttitta F., Carney D. N., Mulshine J., Moody T. W., Fedorko J., Fischler A., and Minna J. D. (1985) Bombesin-like peptides can function as autocrine-like growth factors in human small-cell lung cancer.Nature (Lond.) 316, 823–826.
Dicker P. and Rozengurt E. (1980) Phorbol esters and vasopressin stimulate DNA synthesis by a common mechanism.Nature (Lond.) 287, 607–612.
Dreifuss J. J., Tribollet E., Goumaz M., Dubois-Dauphin M., and Raggenbass M. (1991) Vasopressin receptor localization and neuronal responsiveness in the rat brain, inVasopressin, Jard S. and Jamison R., eds., Colloque INSERM/John Libbey Eurotext, Paris, pp. 159–166.
Gainer H., Alstein M., and Whitnall M. H. (1987) The cell biology and development of vasopressinergic and oxytocinergic neurons, inProg. Brain Res., vol. 72, de Kloet E. R., Wiegent V. M., and de Weid, D., eds., Elsevier, Amsterdam, pp. 153–161.
Guillon G., Kirk C. J., and Balestre M-N. (1986) Characterization of specific Vla vasopressin-binding sites on a rat mamary-tumor-cell line.Biochem. J. 240, 189–196.
Habener J. F., Cwikel B. J., Hermann H., Hammer R. E., Palmiter R. D., and Brinster R. L. (1989) Metallothionein-Vasopressin fusion brain gene expression in transgenic mice.J. Biol. Chem. 264, 18,844–18,852.
Herschman H. R. (1991) Primary response genes induced by growth factors and tumor promoters.Annu. Rev. Biochem. 60, 281–319.
Hunt N. H., Perris A. D., and Sandford P. A. (1977) Role of vasopressin in the mitogenic response of rat bone marrow cells to haemorrhage.J. Endocrinol. 72, 5–16.
Ifft J. D. (1972) An autoradiographic study of the time of final division of neurons in rat hypothalamic nuclei.J. Comp. Neurol. 144, 193–204.
Isler H. (1974) Loss of mitotic response of the thyroid gland to TSH in hypophysectomized rats its partial restoration by anterior and posterior pituitary hormones.Anat. Rec. 180, 369–376.
Jard S. (1983) Vasopressin: mechanisms of receptor activation, inProg. Brain Res. vol. 60, Cross B. A. and Leng G., eds., Elsevier, Amsterdam, pp. 383–394.
Jard S., Gailard J. M. R., Guillon G., Marie J., Schoenenberg P., Muller A. F., Manning M., and Sawyer W. H. (1986) Vasopressin antagonists allow demonstration of a novel type of vasopressin receptors in the rat adenohypophysis.Mol. Pharmacol. 30, 171–177.
Kirk C. J., Guillon G., Balestre M-N., and Jard S. (1986) Stimulation, by vasopressin and other agonists, of inositol-lipid breakdown and inositol phosphate accumulation in WRK 1 cells.Biochem. J. 240, 197–204.
Laurent F. M., Hindelang C., Klein M. J., Stoeckel M. E., and Felix J. M. (1989) Expression of the oxytocin and vasopressin genes in the rat hypothalamus during development: an in situ hybridization study.Dev. Brain Res. 46, 145–154.
McNicol A. M., Murray J. E., and McMeekin W. (1990) Vasopressin stimulation of cell proliferation in the rat pituitary gland in vitro.J. Endocrinol. 126, 255–259.
Millar J. B. A. and Rozengurt E. (1989) Heterologous desensitization of bombesin-induced mitogenesis by prolonged exposure to vasopressin: A post-receptor signal transduction block.Proc. Natl. Acad. Sci. USA 86, 3204–3208.
Miller R. P., Husain F., Svensson M., and Lohin S. (1977) Enhancement of (3H-methyl) thymidine incorporation and replication of rat chondrocytes grown in tissue culture by plasma, tissue extracts and vasopressin.Endocrinology 100, 1365–1447.
Mohr E., Fehr S., and Richter D. (1991) Axonal transport of neuropeptide encoding mRNAs within the hypothalamo-hypophyseal tract of rats.EMBO J. 10, 2419–2424.
Monaco M. E., Lippmann M. E., Knazek R., and Kidwell W. R. (1978) Vasopressin stimulation of acetate incorporation in lipids in a dimethylbenz(a) anthracene-induced rat mammary tumor cell line.Cancer Res. 38, 4101–4104.
Morano M. I. and Estivariz F. E. (1989) Corticatropin-releasing factor and vasopressin production in the rat pituitary tumor 7315a: Biochemical and immunohistochemical studies.Cancer Res. 49, 2755–2760.
Morel A., O’Carroll A.-M., Brownstein M. J., and Lolait S. J. (1992) Molecular cloning and expression of a rat Vla arginine vasopressin receptor.Nature 356, 523–526.
Mullins L. and Mullins J. (1991) Transgenic approaches to modification of cell and tissue function.Curr. Opin. Cell Biol. 3, 192–198.
Nambi P., Watt R., Whitman M., Aiyer N., Moore J. P., Evan G. I., and Crooke S. (1989) Induction of c-fos protein by activation of vasopressin receptors in smooth muscle cells.FEBS Lett. 245, 61–64.
North W. G. and Yu X-M. (1991) Vasopressin mRNA and Neurophysin-related cell-surface antigen (NRSA) of small-cell carcinoma(SCCL).Soc. Neurosci. Abstr. 21, 165.11.
Oosterbaan H. P., Swaab D. F., and Boer G. J. (1985a) Oxytocin and vasopressin in the rat do not readily pass from the mother to the amniotic fluid in late pregnancy.J. Dev. Physiol. 7, 55–62.
Oosterbaan H. P., Swaab D. F., and Boer G. J. (1985b) Increased amniotic vasopressin levels in experimentally growth-retarded rat fetuses.J. Dev. Physiol. 7, 89–97.
Payet N., Deziel Y., and Lehoux J. G. (1984) Vasopressin: a potent growth factor in adrenal glomerulosa cells in culture.J. Steroid. Biochem. 20, 449–454.
Petracca F. M., Baskin D. G., Diaz J., and Dorsa D. M. (1986) Ontogenetic changes in vasopressin binding site distribution in rat brain: an autoradiographic study.Dev. Brain Res. 28, 63–68.
Rees L. H. (1975) The biosynthesis of hormones by non-endocrine tumours—A review.J. Endocrinol. 67, 143–175.
Rodriguez-Pena A. and Rozengurt E. (1986) Phosphorylation of an acidic molecular weight 80000 cellular protein in a cell-free system and intact Swiss 3T3 cells: a specific marker of protein kinase C activity.EMBO J. 5, 77–84.
Rosenbaum L. C., Neuwelt E. A., Van Tol H. H. M., Loh Y. P., Verbalis J. G., Hellstrom I., Hellstrom K. E., and Nilaver G. (1990) Expression of neurophysin-related precursor in cell membranes of a small-cell lung carcinoma.Proc. Natl. Acad. Sci. USA 87, 9928–9932.
Rozengurt E. (1986) Early signals in the mitogenic response.Science 234, 161–166.
Rozengurt E. (1989) Signal transduction pathways in mitogenesis.Br. Med. Bull.,45, 515–528.
Rozengurt E., Brown K. D., and Pettican P. (1981) Vasopressin inhibition of epidermal growth factor binding to cultured mouse cells.J. Biol. Chem. 256, 716–722.
Rozengurt E., Legg A., and Pettican P. (1979) Vasopressin stimulation of mouse 3T3 cell growth.Proc. Natl. Acad. Sci. USA 76, 1284–1287.
Russell W. E. and Bucher N. L. R. (1983) Vasopressin modulates liver regeneration in the Brattleboro rat.Am. J. Physiol. 245, 321–324.
Sethi T. and Rozengurt E. (1991) Multiple neuropeptides stimulate clonal growth of small cell lung cancer: Effects of bradykinin, vasopressin, cholecystokinin, galanin, and neurotensin.Cancer Res. 51, 3621–3623.
Taylor A. H., Ang V. T. Y., Jenkins J. S., Silverlight J. J., Coombes R. C., and Luqmani Y. A. (1990) Interaction of vasopressin and oxytocin with human breast carcinoma cells.Cancer Res. 50, 7882–7886.
Tribollet E., Charpak S., Schmidt A., Dubois-Dauphin M., and Dreifuss J. J. (1989) Appearance and transient expression of oxytocin receptors in fetal, infant and peripubertal rat brain studied by autoradiography and electrophysiology.J. Neurosci. 9, 1764–1773.
Tribollet E., Goumaz M., Raggenbass M., and Dreifuss J. J. (1991) Appearance and transient expression of vasopressin and oxytocin receptors in the rat brain.J. Recep. Res., in press.
Uylings H. B. M. and Van Norde W. (1986) Impaired development of individual cerebellar lobules in the diabetes insipidus Brattleboro rat.Dev. Brain Res. 26, 293–300.
Verbeek M. (1990) Studies of neuropeptide gene expression in tumor cell lines. Thesis. University of Utrecht, The Netherlands.
Walsh-Reitz M. M. and Toback F. G. (1983) Vasopressin stimulates growth of renal epithelial cells in culture.Am. J. Physiol. 245, 365–370.
Whitfield J. F., MacManus J. P., and Gillan D. J. (1970) The possible mediation by cAMP of the stimulation of thymcyte proliferation by vasopressin and the inhibition of this mitogenic action by thyrocalcitonin.J. Cell Physiol. 76, 65–76.
Whitnall M. H., Key S., Ben-Barak Y., Ozato K., and Gainer H. (1985) Neurophysin in the hypothalamoneurohupophyseal system. II. Immunocytochemical studies of the ontogeny of oxytocinergic and vasopressinergic neurons.J. Neurosci. 5, 98–109.
Winkler W. A. and Crankshaw O. F. (1938) Chloride depletion in conditions other than Addison’s disease.J. Clin. Invest. 17, 1–6.
Woll P. J. and Rozengurt E. (1989a) Neuropeptides as growth regulators.Br. Med. Bull. 45, 492–505.
Woll P. J. and Rozengurt E. (1989b) Multiple neuropeptides mobilise calcium in small cell lung cancer: Effects of vasopressin, bradykinin, cholecystokinin, galanin and neurotensin.Biochem. Biophys. Res. Commun. 164, 66–73.
Woll P. J. and Rozengurt E. (1990) A neuropeptide that inhibits the growth of small cell lung cancer in vitro.Cancer Res. 50, 3968–3973.
Worley R. T. S. and Pickering B. T. (1984) Non-neuronal cells of rat hypothalamus in dissociated cell culture.Cell Tiss. Res. 237, 161–168.
Zachery I. and Rozengurt E. (1986) A substance P antagonist also inhibits specific binding and mitogenic effects of vasopressin and bombesin-related peptides in Swiss 3T3 cells.Biochem. Biophys. Res. Commun. 137, 135–141.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Carter, D.A., Fai, C.K. & Murphy, D. Neurohypophyseal peptides as regulators of growth and development. J Mol Neurosci 4, 11–19 (1993). https://doi.org/10.1007/BF02736686
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF02736686